[{"AccountsPayableCurrent_0_Q3_USD":4733000.0,"ProceedsFromCollaborators_3_Q3_USD":1000000000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":34343000.0,"PreferredStockValue_0_Q3_USD":null,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":1671399000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":796000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":110000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":31000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":103000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-721000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-21000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":-721000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-21000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":-21000.0,"OtherAssetsNoncurrent_0_Q3_USD":3875000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":661000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":17432000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":12481000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":7414000.0,"OperatingIncomeLoss_3_Q3_USD":-335422000.0,"OperatingIncomeLoss_1_Q3_USD":-130894000.0,"OperatingExpenses_3_Q3_USD":340088000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":14300000.0,"OperatingExpenses_1_Q3_USD":132334000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":699212000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":7956000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":58593743.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":58819548.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":58593743.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":58819548.0,"TreasuryStockCommonValue_0_Q3_USD":400000.0,"TreasuryStockCommonShares_0_Q3_shares":3033.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":430000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":1825000.0,"StockholdersEquity_0_Q3_USD":1835654000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":8644442.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":53.42,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q3_shares":5687262.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0_Q3_shares":1006718.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3_Q3_shares":0.0,"ShareBasedCompensation_3_Q3_USD":83981000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":131899000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":48706000.0,"Revenues_3_Q3_USD":4666000.0,"Revenues_1_Q3_USD":1440000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1370674000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q3_USD":1269000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":207723000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":83497000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":2907000.0,"PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease_3_Q3_USD":-1800000.0,"ProfitLoss_3_Q3_USD":-333180000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":58819548.0,"NetIncomeLoss_3_Q3_USD":-333180000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-280681000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-1239364000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":423434000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q3_USD":422165000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":422165000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":1421004000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":1421310000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":429000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":123000.0,"AssetsFairValueDisclosure_0_Q3_USD":1843169000.0,"AssetsCurrent_0_Q3_USD":1901697000.0,"Assets_0_Q3_USD":1927180000.0,"AssetImpairmentCharges_3_Q3_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":7054853.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":7054853.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":83981000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":34342000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":34079000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":3207028000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-306000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease_3_Q3_USD":-1800000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":5049000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":9965000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":66795000.0,"AccountsReceivableRelatedPartiesCurrent_0_Q3_USD":24185000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"NetIncomeLoss_1_Q3_USD":-130171000.0,"CommonStockSharesAuthorized_0_Q3_shares":120000000.0,"CommonStockSharesOutstanding_0_Q3_shares":58832373.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-972187000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":13504000.0,"MarketableSecuritiesCurrent_0_Q3_USD":1421004000.0,"LiabilitiesCurrent_0_Q3_USD":78942000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":1927180000.0,"Liabilities_0_Q3_USD":91526000.0,"InvestmentsFairValueDisclosure_0_Q3_USD":1421004000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_3_Q3_USD":-8722000.0,"InterestIncomeExpenseNonoperatingNet_3_Q3_USD":2132000.0,"InterestIncomeExpenseNonoperatingNet_1_Q3_USD":692000.0,"IncrementalCommonSharesAttributableToConversionOfPreferredStock_3_Q3_shares":0.0,"IncrementalCommonSharesAttributableToConversionOfPreferredStock_1_Q3_shares":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":11522000.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":534000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":11315000.0,"IncreaseDecreaseInAccountsReceivableRelatedParties_3_Q3_USD":24185000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":1042000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":11393000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-5.69,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-2.21,"Depreciation_3_Q3_USD":3849000.0,"Depreciation_1_Q3_USD":400000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-333901000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-130192000.0,"CommonStockValue_0_Q3_USD":6000.0,"CommonStockSharesIssued_0_Q3_shares":58835406.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":58593743.0,"Ticker":"SAGE","CIK":"1597553","name":"SAGE THERAPEUTICS, INC.","OfficialName":"Sage Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2034401653.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211102"}]